Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to 0.4%.

  • Abvc Biopharma's Return on Capital Employed rose 23100.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year increase of 23100.0%. This contributed to the annual value of 8.31% for FY2024, which is 49900.0% down from last year.
  • Latest data reveals that Abvc Biopharma reported Return on Capital Employed of 0.4% as of Q3 2025, which was up 23100.0% from 0.44% recorded in Q2 2025.
  • Over the past 5 years, Abvc Biopharma's Return on Capital Employed peaked at 0.4% during Q3 2025, and registered a low of 6.61% during Q1 2024.
  • For the 5-year period, Abvc Biopharma's Return on Capital Employed averaged around 2.14%, with its median value being 1.8% (2022).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 95800bps in 2021, then tumbled by -44900bps in 2024.
  • Abvc Biopharma's Return on Capital Employed (Quarter) stood at 1.25% in 2021, then crashed by -169bps to 3.37% in 2022, then soared by 64bps to 1.22% in 2023, then tumbled by -250bps to 4.27% in 2024, then surged by 91bps to 0.4% in 2025.
  • Its Return on Capital Employed was 0.4% in Q3 2025, compared to 0.44% in Q2 2025 and 0.57% in Q1 2025.